
IMF In-Person Regional Community Workshop (RCW) - Baltimore
Date and Location:
Saturday, June 17th, 2023 9:00 a.m. — 3:00 p.m. EST
J. Millard Tawes Ballroom, Coppin State University
2500 W North Avenue, Baltimore MD 21216
The IMF Regional Community Workshop will include an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. A member of the IMF Nurse Leadership Board will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.




Welcome and Announcements
Kelly Cox, Senior Director IMF Regional Community Workshops
Myeloma 101 and Relapsed Therapies & Clinical Trials
David Vesole, MD, PhD, reviews multiple myeloma basics including what myeloma is, common symptoms and side effects, advances in how myeloma is initially diagnosed, the stages of myeloma treatment, induction therapy, transplant, and more.
Frontline Therapy and Maintenance Therapy
Ashraf Badros, MD , discusses the types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, updates on clinical trials, and more.
Managing Multiple Myeloma Symptoms and Treatment Side Effects
Kevin Brigle PhD, NP (IMF Nurse Leadership Board) discusses how patients can manage myeloma-related symptoms and side effects along with side effects brought on by treatment. She outlines the most common side effects for each myeloma drug category, how to prevent infection, and more.
Patient Perspective: Hear the Journey of a Local Myeloma Patient and Their Care Partner.
Bonnie Downing and Laura English, Myeloma Patients (Baltimore, MD) discuss the journey of a local myeloma patient and their care partner.
8:00 – 9:00 AM | Registration |
9:00 – 11:55 AM | Morning Session |
11:55 – 12:40 PM | Lunch |
12:40 – 2:45 PM | Afternoon Session |
2:45 – 3:00 PM | Coffee / Network |








